The FDA has cleared BeOne Medicines’ BCL2 blocker sonrotoclax for the treatment of certain patients with mantle cell lymphoma ...

Not all cancers respond to the same treatments or have the same genetic origins. Epstein–Barr virus (EBV), a common and ...

Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care ...

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

A Putnam County high school sophomore was diagnosed with a rare form of lymphoma and is beginning intensive chemotherapy ...

Lymphoma is a cancer of lymphocyte cells. Lymphocytes are one of our white blood cells and they play an important role in helping our body to fight off infection. They are present in lymph fluid which ...

Diamantas takes the reins, Regenxbio stakes claim in Duchenne gene therapy, and more biotech news from The Readout ...

New research shows that lymphoma survivors often face long-term peripheral neuropathy, which may be more severe than what ...

EZH2 inhibitor tazemetostat (Tazverik) is being withdrawn from global markets ...

MISSION VIEJO, Calif. (KABC) -- Actor Jeff Bridges announced he's fighting a major battle. The Oscar winner on Tuesday tweeted that he's been diagnosed with lymphoma. "I have been diagnosed with ...

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an "identity crisis." Normally, a B cell ...

New population studies suggest that tattoos may be associated with a higher risk for lymphoma and skin cancer, although ...